International Cannabis Weekly: 142

• Charlotte Figi, who helped champion CBD for medical use sadly passes.
• Ontario eases cannabis sale laws to combat the black market.
• US businesses working indirectly with cannabis are ineligible for COVID-19 loans.
• Ireland imports emergency cannabis supplies for ministerial licensed patients.
• French cannabis reforms halted following industrial action and COVID-19 concerns.
• COVID-19 disrupts EU-GMP inspections across the globe, limiting export markets.
• Spanish cannabis social clubs propose rules to stay open during lockdown.

• Prohibition Partners launches The Oceania Cannabis Report: Second Edition.
• Lithuania approves final amendments to CBD and hemp-oil production bill.
• DEA removes Epidiolex from the controlled substances list.

• Albanian PM says the country is considering medical cannabis cultivation.
• BfArM rejects application for Berlin recreational cannabis pilot project.
• Number of Danish patients accessing cannabis plummets as supply is interrupted.
• Italian medical cannabis sales grew by 50% in 2019
• Alphagreen announces appointment of new board of advisers and chairman.

• Canada’s CBD drinks space remains hopeful for growth despite early delays.
• Canadian cannabis businesses now eligible for government loans.
• Canopy Growth temporarily lays off 200 staff and plans to re-open select stores.
• Vancouver’s Choom Holdings continues expansion with Ontario retail acquisition.

• Reform groups urge Virginia governor to amend cannabis decriminalisation bill.
• FBI to review policy on agents and employees using CBD products.
• Audit of Los Angeles cannabis licensing programme finds ‘no evidence of bias’.
• AXIM Biotec receives US patent for nicotine and cannabinoid chewing gum.
• Acreage Holdings announces temporary closures and employee furloughs.

• Emergency measures help Australian medical cannabis patients access treatment.
• First medical cannabis capsules made available on prescription in Australia.
• Cannabis use in Hong Kong rises by 50%, spurred by legalisation abroad.
• Licensed producers avoid ‘non-essential’ status as Australia limits domestic industries.

• Jacana donates thousands of masks and PPE to Jamaican healthcare workers.
• Khiron provides resources and support in Colombia alongside new teleconsultations.
• Meet the activists campaigning for medical cannabis access in Latin America.

• Ghana’s Mental Health Authority suggests cannabis legalisation will increase drug abuse.
• Israel’s Panaxia gains rights to Maltese R&D facility ahead of European expansion.

• Researchers are collecting anonymous data on cannabis-use patterns during COVID-19.
• Legal recreational cannabis states had fewer vape-related lung injuries, study finds.

• Champignon Brands to acquire government licensed psychedelic clinics, AltMed.
• Former adviser urges UK government to relax rules on psychedelic drug research.
• Psilocybin affects the brain after it leaves the user’s system, finds new research.
• Psilocybin and LSD show persistent anti-depressive effects in new animal study.

Prohibition Partners is proud to launch The Oceania Cannabis Report: Second Edition. The report contains expert analysis on the latest industry developments across Australia, New Zealand and the surrounding islands, which is set to be worth $US1.55 billion by 2024.

Download your free copy of the report, here.

JOIN THE WAITLIST